๐ฐ Gen Li News
Gen Li News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Gen Li. Real-time updates on events, politics, business and more.
June 3, 2024
A new study from the University of Michigan Health Rogel Cancer Center reveals a connection between the most common type of white blood cells, which act as a first defense in the bodys immune system, and a severe complication of CAR T-Cell immunotherapy.
May 31, 2024
It is the first in-person meeting at this level between the two sides in 18 months. Read more at straitstimes.com.
May 28, 2024
Global cancer trial investigator sites have increased 50% in just five years but led to a rise in the number of poorly performing sites, new research ha...
May 23, 2024
Clinical trial sites for cancer are proliferating, but a lack of investigators with experience in trial recruitment is weighing on their performance.
May 23, 2024
Global oncology trial investigator sites increase by half in five years, finds new Phesi analysis
February 27, 2024
The Standing Committee of the National Peoples Congress (NPC), which concluded its session here on Tuesday, said in a statement that the Tianjin Municipal Peoples Congress accepted Qins resignation as a delegate to the upcoming annual parliamentary session, state-run Xinhua news agency reported.
February 27, 2024
The Standing Committee of the National Peoples Congress (NPC), which concluded its session here on Tuesday, said in a statement that the Tianjin Municipal Peoples Congress accepted Qins resignation as a delegate to the upcoming annual parliamentary session, state-run Xinhua news agency reported.
February 11, 2024
Phesiโs artificial intelligence (AI) driven platform, Trial Accelerator, has reached a milestone and now contains global data from more than 100 million patients.
February 6, 2024
Phesiโs artificial intelligence (AI) driven platform, Trial Accelerator, has reached a milestone and now contains global data from more than 100 million patients.
January 17, 2024
Phesi releases 2023 analysis of clinical development; breast cancer remains most studied disease area for third year